AU6370186A - Recombinant vaccinia virus sxpresses hybrid polypeptides on virus infected cell surface - Google Patents

Recombinant vaccinia virus sxpresses hybrid polypeptides on virus infected cell surface

Info

Publication number
AU6370186A
AU6370186A AU63701/86A AU6370186A AU6370186A AU 6370186 A AU6370186 A AU 6370186A AU 63701/86 A AU63701/86 A AU 63701/86A AU 6370186 A AU6370186 A AU 6370186A AU 6370186 A AU6370186 A AU 6370186A
Authority
AU
Australia
Prior art keywords
virus
sxpresses
cell surface
infected cell
recombinant vaccinia
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
AU63701/86A
Other versions
AU594087B2 (en
Inventor
Stirling John Edwards
Christopher John Langford
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Saramane Pty Ltd
Original Assignee
Saramane Pty Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Saramane Pty Ltd filed Critical Saramane Pty Ltd
Publication of AU6370186A publication Critical patent/AU6370186A/en
Application granted granted Critical
Publication of AU594087B2 publication Critical patent/AU594087B2/en
Assigned to SARAMANE PTY LTD reassignment SARAMANE PTY LTD Alteration of Name(s) in Register under S187 Assignors: WALTER AND ELIZA HALL INSTITUTE OF MEDICAL RESEARCH, THE
Anticipated expiration legal-status Critical
Ceased legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09—Recombinant DNA-technology
    • C12N15/63—Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
    • C12N15/79—Vectors or expression systems specially adapted for eukaryotic hosts
    • C12N15/85—Vectors or expression systems specially adapted for eukaryotic hosts for animal cells
    • C12N15/86—Viral vectors
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/44—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from protozoa
    • C07K14/445—Plasmodium
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09—Recombinant DNA-technology
    • C12N15/11—DNA or RNA fragments; Modified forms thereof; Non-coding nucleic acids having a biological activity
    • C12N15/62—DNA sequences coding for fusion proteins
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N7/00—Viruses; Bacteriophages; Compositions thereof; Preparation or purification thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K2319/00—Fusion polypeptide
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K2319/00—Fusion polypeptide
    • C07K2319/40—Fusion polypeptide containing a tag for immunodetection, or an epitope for immunisation
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K2319/00—Fusion polypeptide
    • C07K2319/61—Fusion polypeptide containing an enzyme fusion for detection (lacZ, luciferase)
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2710/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA dsDNA viruses
    • C12N2710/00011—Details
    • C12N2710/24011—Poxviridae
    • C12N2710/24111—Orthopoxvirus, e.g. vaccinia virus, variola
    • C12N2710/24141—Use of virus, viral particle or viral elements as a vector
    • C12N2710/24143—Use of virus, viral particle or viral elements as a vector viral genome or elements thereof as genetic vector
AU63701/86A 1985-08-29 1986-08-29 Recombinant vaccinia virus sxpresses hybrid polypeptides on virus infected cell surface Ceased AU594087B2 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
AUPH2198 1985-08-29
AUPH219885 1985-08-29

Publications (2)

Publication Number Publication Date
AU6370186A true AU6370186A (en) 1987-03-24
AU594087B2 AU594087B2 (en) 1990-03-01

Family

ID=3771250

Family Applications (1)

Application Number Title Priority Date Filing Date
AU63701/86A Ceased AU594087B2 (en) 1985-08-29 1986-08-29 Recombinant vaccinia virus sxpresses hybrid polypeptides on virus infected cell surface

Country Status (11)

Country Link
EP (1) EP0244427A4 (en)
JP (1) JPS63500637A (en)
KR (1) KR880700073A (en)
AU (1) AU594087B2 (en)
DK (1) DK219187A (en)
ES (1) ES2002128A6 (en)
FI (1) FI871885A (en)
IL (1) IL79880A0 (en)
NZ (1) NZ217400A (en)
WO (1) WO1987001386A1 (en)
ZA (1) ZA866582B (en)

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1989007140A1 (en) * 1988-02-05 1989-08-10 Commonwealth Scientific And Industrial Research Or Gene expression system (particularly for rotavirus vp7 protein) involving a foreign signal peptide and optionally a transmembrane anchor sequence

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5182211A (en) * 1987-08-07 1993-01-26 Institut Pasteur Plasmid vectors encoding a protein of a picornavirus
FR2663228A2 (en) * 1989-09-29 1991-12-20 Agronomique Inst Nat Rech Immunising composition against Newcastle disease and method of preparation
US8101189B2 (en) 2002-07-05 2012-01-24 Folia Biotech Inc. Vaccines and immunopotentiating compositions and methods for making and using them
DK1523329T3 (en) 2002-07-05 2013-10-14 Folia Biotech Inc Virus particle adjuvant

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2442271A1 (en) * 1978-11-27 1980-06-20 Pasteur Institut VECTOR FOR THE INSERTION OF A PROKARYOTE OR EUKARYOTE GENE, AND EXCRETION OF THE EXPRESSED PROTEIN
US4603112A (en) * 1981-12-24 1986-07-29 Health Research, Incorporated Modified vaccinia virus
US4593002A (en) * 1982-01-11 1986-06-03 Salk Institute Biotechnology/Industrial Associates, Inc. Viruses with recombinant surface proteins
JPH0795954B2 (en) * 1982-11-30 1995-10-18 アメリカ合衆国 Method for producing recombinant poxvirus for expression of foreign gene
AU569722B2 (en) * 1983-01-28 1988-02-18 Saramane Pty Ltd Expression of plasmodium falciparum polypeptides from cloned cdna
EP0162738A1 (en) * 1984-04-09 1985-11-27 MOLECULAR GENETICS RESEARCH & DEVELOPMENT LIMITED PARTNERSHIP Production of pseudorabies virus subunit vaccines
FR2563434B1 (en) * 1984-04-25 1986-07-25 Transgene Sa Rabies vaccine and process for its preparation

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1989007140A1 (en) * 1988-02-05 1989-08-10 Commonwealth Scientific And Industrial Research Or Gene expression system (particularly for rotavirus vp7 protein) involving a foreign signal peptide and optionally a transmembrane anchor sequence

Also Published As

Publication number Publication date
EP0244427A4 (en) 1989-04-27
KR880700073A (en) 1988-02-15
DK219187D0 (en) 1987-04-29
JPS63500637A (en) 1988-03-10
NZ217400A (en) 1989-09-27
WO1987001386A1 (en) 1987-03-12
EP0244427A1 (en) 1987-11-11
ZA866582B (en) 1987-04-29
FI871885A0 (en) 1987-04-29
AU594087B2 (en) 1990-03-01
IL79880A0 (en) 1986-11-30
ES2002128A6 (en) 1988-07-16
DK219187A (en) 1987-04-29
FI871885A (en) 1987-04-29

Similar Documents

Publication Publication Date Title
AU569821B2 (en) Oxa-azahomocyclostatine polypeptides
AU1628895A (en) Recombinant virus
GB2125065B (en) Viruses with recombinant surface proteins
AU7831787A (en) Improved recombinant expression
GB8821528D0 (en) Recombinant vaccinia virus
AU1376688A (en) Recombinant avipoxvirus
AU576468B2 (en) Functionalised monomers
AU6255086A (en) Reference electrode
AU5319886A (en) Immunoregulatory peptides
AU590016B2 (en) Peptides
AU6123686A (en) Biologically-active copolymers
AU6241686A (en) Infectious recombinant virus vaccine for feline leukemia
AU6170486A (en) Defective viral vaccines
AU572732B2 (en) Battery mounted electromagnetic switch
AU7268287A (en) Hybrid polypeptides comprising somatocrinine and alpha -antitrypsin
AU6370186A (en) Recombinant vaccinia virus sxpresses hybrid polypeptides on virus infected cell surface
AU1865788A (en) Recombinant vaccinia virus expressing hsv 1 gb
AU585780B2 (en) Angle demodulator
AU4474589A (en) Recombinant interleukin-2 hybrid proteins
AU582208B2 (en) Improved active dried yeast
AU5769486A (en) Electrofilter with improved electrode
AU8132287A (en) Recombinant vaccinia virus
AU610821B2 (en) Recombinant inhibin
AU8075787A (en) Recombinant poxviruses
AR243297A1 (en) Recombinant battery and plate separator therefor